Coronaviruses pp 551-557 | Cite as

Stratagies for a Successful Coronavirus (TGE) Vaccine for Swine

  • C. Joseph Welter
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 218)

Abstract

Transmissible gastroenteritis (TGE) is a coronaviral enteric disease in swine responsible for substantial economic loss to the swine industry. Fifteen percent of nursing piglet diarrheas in the Midwestern States can be attributed to TGE.1 The natural route of infection is oral, with viral replication occuring in the small intestine, and leading to watery diarrhea, rapid dehydration and death of piglets under two weeks of age. Viremia and other localized infections do not appear to be prevalent during the course of the disease although infectious virus has been isolated from the lungs of clinically normal adult pigs.2

Keywords

Passive Immunity Oral Vaccine Oral Vaccination Substantial Economic Loss Unvaccinated Control 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ambico, Inc. Diagnostic Services, 1935-1986.Google Scholar
  2. 2.
    Underdahl, N.R., Mebus, C.A., Stair, E.L., Rhodes, M.B., McGill, L.D. and M. J. Twiehaus. Am.J.Vet.Res. 35: 1209 (1974).PubMedGoogle Scholar
  3. 3.
    Welter, C.J. Vet.Med. 60: 1054 (1965).Google Scholar
  4. 4.
    Tamoglia, T.W. J.A.V.M.A. 160: 554 (1972).Google Scholar
  5. 5.
    Welter, C.J. VM/SAC. 75: 1757 (1980).Google Scholar
  6. 6.
    Graham, J.A. VM/SAC. 75: 1618 (1980).Google Scholar
  7. 7.
    Saif, L., Bohl, E.H., and R. Gupta. Infection and Immunity. 6: 600 (1972).PubMedGoogle Scholar
  8. 8.
    Fitzgerald, G.R., Welter, M.W., and C.J. Welter. Vet.Med. 81: 184 (1986).Google Scholar
  9. 9.
    Saif, L., and E.H. Bohl. Ohio Swine Res. and Ind. Rep. OARDC. pp 58-59 (1981).Google Scholar
  10. 10.
    Hu, S., Bruszewski, J., Boone, T., and L. Souza. Mod. Approaches to Vaccines, edited by R.M. Chanock and R.A. Lerner. pp 219-223 (1984).Google Scholar
  11. 11.
    Hu, S., Bruszewski, and R. Smalling. Vaccinia Viruses as Vectors for Vaccine Antigens. WHO/PHS Conf. ppII-114 (1984).Google Scholar
  12. 12.
    Gough, P.M., Ellis, C.H., Frank, C.J. and C.J. Johnson. Antiviral Res. 3: 211 (1983).PubMedCrossRefGoogle Scholar
  13. 13.
    Gough, P.M., Frank, C.J., Moore, D.G., Sagona, M.A., and C.J. Johnson. Vaccine. 1: 37 (1983).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • C. Joseph Welter
    • 1
  1. 1.Ambico, Inc.Dallas CenterUSA

Personalised recommendations